GADICKE ANSBERT

10% owner at TERCICA INC · on record since Mar 16, 2004
10% owner at HELICOS BIOSCIENCES CORP · on record since May 31, 2007
10% owner at Acorda Therapeutics, Inc. · on record since Feb 9, 2006
10% owner at PONIARD PHARMACEUTICALS, INC. · on record since Apr 27, 2006
10% owner at Restore Medical, Inc. · on record since May 24, 2006
10% owner at Omrix Biopharmaceuticals, Inc. · on record since Apr 11, 2006
10% owner at AVEO PHARMACEUTICALS, INC. · on record since Mar 12, 2010
10% owner at MEMORY PHARMACEUTICALS CORP · on record since Oct 18, 2006
10% owner at AFFYMAX INC · on record since Dec 21, 2006
Former 10% Owner at Omrix Biopharmaceuticals, Inc. · on record since Nov 6, 2006
10% owner at SENORX INC · on record since Mar 28, 2007
Former 10% Owner at CORNERSTONE THERAPEUTICS INC · on record since Feb 15, 2007
10% owner at VIACELL INC · on record since Feb 12, 2007
10% owner at COTHERIX INC · on record since Jan 10, 2007
10% owner at ALUS Liquidation Corp · on record since Jun 28, 2007
Director at Pharmasset Inc · on record since Apr 26, 2007
10% owner at Pharmasset Inc · on record since Apr 26, 2007
10% owner at CRYOCOR INC · on record since Apr 25, 2007
10% owner at · on record since May 10, 2007
10% owner at · on record since Nov 13, 2007
10% owner at · on record since Sep 14, 2007
10% owner at · on record since Aug 10, 2007
See explanation below at · on record since Aug 7, 2007
10% owner at · on record since Apr 28, 2004
10% owner at · on record since Nov 21, 2007
Former 10% Owner at · on record since May 15, 2025
10% owner at · on record since Oct 30, 2008
Former 10% Owner at · on record since Jun 23, 2008
Former 10% Owner at · on record since Dec 4, 2025
10% owner at · on record since Apr 18, 2008
10% owner at · on record since Jun 16, 2008
10% owner at · on record since May 29, 2009
10% owner at · on record since Jan 14, 2026
10% owner at · on record since Jul 8, 2003
10% owner at · on record since Dec 22, 2009
10% owner at · on record since May 25, 2004
Former 10% Stockholder at · on record since Mar 18, 2010
Former 10% Owner at · on record since Dec 15, 2010
10% owner at · on record since Feb 17, 2011
Director at · on record since May 19, 2011
Director at · on record since Jan 26, 2012
10% owner at · on record since Aug 10, 2012
10% owner at · on record since Jul 21, 2004
Director at · on record since Jul 21, 2004
Former 10% Owner at · on record since Mar 13, 2013
10% owner at · on record since May 30, 2013
10% owner at · on record since Jun 26, 2013
10% owner at · on record since Jul 24, 2013
10% owner at · on record since Apr 23, 2014
10% owner at · on record since Mar 10, 2004
Former 10% Owner at · on record since Sep 15, 2004
Director at · on record since Jul 21, 2015
10% owner at · on record since Jul 21, 2015
10% owner at · on record since Oct 20, 2015
10% owner at · on record since Mar 9, 2016
Director at · on record since Jan 19, 2005
10% owner at · on record since Oct 11, 2017
See Remarks at · on record since Mar 3, 2005
Director at · on record since Feb 21, 2019
10% owner at · on record since Feb 21, 2019
10% owner at · on record since Feb 14, 2019
10% owner at · on record since Jun 25, 2020
Director at · on record since Jul 31, 2020
10% owner at · on record since Jul 31, 2020
Director at · on record since Jul 30, 2020
10% owner at · on record since Jul 30, 2020
10% owner at · on record since Sep 23, 2020
10% owner at · on record since Oct 8, 2020
Director at · on record since Jan 14, 2021
10% owner at · on record since Jan 14, 2021
10% owner at · on record since Apr 29, 2021
10% owner at · on record since Oct 28, 2021
Former Director at · on record since Feb 10, 2023
10% owner at · on record since Jun 13, 2005
Former 10% owner at · on record since Aug 17, 2005

Insider trading activity of GADICKE ANSBERT

Transactions on record: 402; since Jul 7, 2004

Open-market buys: 18; $91.8M

Open-market sells: 165; $108.3M

Companies traded: 29; last filing Jan 14, 2026

Figures computed from official regulatory filings — .

Companies where GADICKE ANSBERT has traded

7 tx · $20M · Jan 14, 2026
32 tx · $20.9M · Jun 5, 2023
59 tx · $16.7M · Feb 10, 2023
6 tx · $15M · Aug 1, 2022
17 tx · $18M · Jan 6, 2022
57 tx · $55.7M · Jul 13, 2021
27 tx · $16.2M · May 6, 2021
10 tx · $4.9M · Oct 8, 2020
63 tx · $25M · Feb 22, 2017
9 tx · Jun 13, 2016
6 tx · Mar 9, 2016
1 tx · $538.5K · Mar 11, 2014
1 tx · $13.6M · Feb 11, 2014
7 tx · $1.9M · Jul 10, 2012

Track record of GADICKE ANSBERT

Statistical track record

Free account

Open-market buys: 23

Last buy: Jan 12, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of GADICKE ANSBERT

Co-insiders of GADICKE ANSBERT

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-22,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Buy	1,112,777	18.00 USD	$20M	conv 70ClusterUnusual size+1	SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	1,314,262	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	5,914,197	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-5,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	1,577,119	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-6,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 5, 2023	Other	-3,370,982	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 5, 2023	Other	-3,854,963	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 5, 2023	Other	-304,001	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	Other	178,269	0.74 USD	$131.9K	Unusual size	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	OtherD (derivative)	-42,761	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	OtherD (derivative)	-135,508	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	Sell	-70,170	1.88 USD	$131.9K		SEC
Cullinan Therapeutics, Inc.Listing on record	Feb 10, 2023	Exercise	350,938	4.30 USD	$1.5M		SEC
Cullinan Therapeutics, Inc.Listing on record	Feb 10, 2023	ExerciseD (derivative)	-88,824	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cullinan Therapeutics, Inc.Listing on record	Feb 10, 2023	ExerciseD (derivative)	-262,114	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 1, 2022	Award	3,253,796	4.61 USD	$15M	Unusual size	SEC
Cullinan Therapeutics, Inc.Listing on record	Jun 23, 2022	AwardD (derivative)	16,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kalaris Therapeutics, Inc.Listing unverified	May 19, 2022	AwardD (derivative)	27,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cullinan Therapeutics, Inc.Listing on record	Mar 25, 2022	AwardD (derivative)	7,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-12,829	46.47 USD	$596.2K		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-11,318	45.32 USD	$512.9K		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-30,347	42.03 USD	$1.3M		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-32,396	43.20 USD	$1.4M	Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-22,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Buy	1,112,777	18.00 USD	$20M	conv 70ClusterUnusual size+1	SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	1,314,262	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	5,914,197	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-5,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	1,577,119	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-6,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 5, 2023	Other	-3,370,982	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 5, 2023	Other	-3,854,963	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 5, 2023	Other	-304,001	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	Other	178,269	0.74 USD	$131.9K	Unusual size	SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	OtherD (derivative)	-42,761	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	OtherD (derivative)	-135,508	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	May 24, 2023	Sell	-70,170	1.88 USD	$131.9K		SEC
Cullinan Therapeutics, Inc.Listing on record	Feb 10, 2023	Exercise	350,938	4.30 USD	$1.5M		SEC
Cullinan Therapeutics, Inc.Listing on record	Feb 10, 2023	ExerciseD (derivative)	-88,824	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cullinan Therapeutics, Inc.Listing on record	Feb 10, 2023	ExerciseD (derivative)	-262,114	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kalaris Therapeutics, Inc.Listing unverified	Aug 1, 2022	Award	3,253,796	4.61 USD	$15M	Unusual size	SEC
Cullinan Therapeutics, Inc.Listing on record	Jun 23, 2022	AwardD (derivative)	16,475	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kalaris Therapeutics, Inc.Listing unverified	May 19, 2022	AwardD (derivative)	27,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cullinan Therapeutics, Inc.Listing on record	Mar 25, 2022	AwardD (derivative)	7,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-12,829	46.47 USD	$596.2K		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-11,318	45.32 USD	$512.9K		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-30,347	42.03 USD	$1.3M		SEC
iTeos Therapeutics, Inc.Listing unverified	Jan 6, 2022	Sell	-32,396	43.20 USD	$1.4M	Unusual size	SEC